Serum S100B and BDNF levels in women with fibromyalgia
Official title: The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor (BDNF) Levels and Central Sensitization and Sleep Quality in Patients With Fibromyalgia
Run by Kanuni Sultan Suleyman Training and Research Hospital · NCT07358754 · Data updated 2026-11-12
This project tests whether blood levels of S100B and BDNF differ in women 18–50 with fibromyalgia compared with healthy women and whether those levels relate to central sensitization and sleep quality.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital Academic / other |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | April 30, 2026 |
| Study ends | April 30, 2026 |
| Registry record updated | April 15, 2026 |
| Trial ID | NCT07358754 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–50 with a diagnosis of fibromyalgia per 2016 ACR criteria, symptoms for at least three months, who can complete questionnaires and provide informed consent.
✕Probably not a fit
Men, people outside the 18–50 age range, individuals without fibromyalgia, or patients seeking immediate therapy changes are unlikely to receive direct benefit from this observational biomarker study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This cross-sectional observational study compares serum S100B and BDNF in women diagnosed with fibromyalgia (2016 ACR criteria) and age- and sex-matched healthy controls. Participants will complete questionnaires on symptoms, central sensitization, and sleep, and provide a single blood sample for biomarker measurement. Analyses will compare biomarker levels between groups and test associations between those levels and measures of central sensitization and sleep quality. The study is designed to clarify biomarker patterns rather than to alter clinical care.
Why it matters
Potential benefit: If successful, the findings could identify blood markers that help explain fibromyalgia symptoms and inform future diagnostic or treatment research.
How similar studies have gone: Previous studies have reported altered BDNF and S100B in chronic pain and fibromyalgia, but results have been inconsistent and not yet definitive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female participants aged between 18 and 50 years Diagnosis of fibromyalgia according to 2016 American College of Rheumatology (ACR) criteria Symptoms present for at least 3 months Ability to understand and complete study questionnaires Provision of written informed consent For healthy controls: No diagnosis of fibromyalgia or chronic widespread pain No known systemic disease Exclusion Criteria: \-
Where it's running
-
Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Zeynep Karakuzu Güngör, M.D — Kanuni Sultan Süleyman Training and Research Hospital
- Study coordinator: Zeynep Karakuzu Güngör, M.D
- Email: zeynepkarakuzu@hotmail.com.tr
- Phone: 905077750375
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Respiratory Function in Fibromyalgia: A Look at Breath and Muscle Health in Women
This study compares respiratory function, muscle strength, and quality of life between women with fibromyalgia and healthy women to see if fibromyalgia affects breathing and muscle performance.
-
Interoceptive Sensitivity and Central Sensitization in Fibromyalgia
This study tests how people with fibromyalgia perceive internal bodily signals and whether that relates to their symptom burden.
-
Psychologically Informed Physical Therapy (PIPT) for Fibromyalgia delivered online
A small online program tests if a psychologically informed physical therapy approach is feasible, acceptable, and safe for adults with fibromyalgia to help manage symptoms and improve daily functioning.
-
Melatonin and vitamin drip for pain relief in fibromyalgia
This trial tests whether weekly intravenous vitamins plus melatonin can reduce pain and improve quality of life for adults with fibromyalgia compared with a placebo.
-
Remote electrical neuromodulation to test pain inhibition in migraine and fibromyalgia
We’re testing if the Nerivio wearable can boost the body’s natural pain-inhibition system (CPM) and reduce pain more than a sham device in adults with migraine or fibromyalgia.
-
Thickness of the thoracolumbar fascia in women with fibromyalgia
This study tests whether the thoracolumbar fascia is thicker in women with fibromyalgia compared to healthy women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.